Abstract
Neuropathic pain conditions cause suffering and disability in many millions of our global citizenry. Nutritional deficiency syndromes, environmental toxicities, AIDS, and other infectious scourges dominate the prevalence pattern of neuropathic pain in many economically challenged parts of the world. More developed parts of the world face a different spectrum of neuropathic pain disorders. In these countries, better prevention and control of many formerly fatal diseases in middle age (e.g., gastrointestinal and pulmonary infections, tuberculosis, heart disease, and certain cancers) create aging populations that accrue risk for chronic conditions associated with neuropathic pain, such as diabetes and cancer. Ironically, in the case of can-cer, even when biomedical treatment successfully remits or cures the disease, these same treatments, such as surgery, chemotherapy, and radiation, often damage nervous tissue, causing chronic neuropathic pain. Hence, the thrill of cure may be obliterated by the enduring agony of a life preserved in chronic pain. Fortunately, the growing incidence of neuropathic pain is concomitant with an explosion of knowledge about the neurophysiology of pain, the phenomenology and pathophysiology of neuropathic pain as a disease, and the mechanisms underlying the effectiveness of a rapidly growing armamentarium of pharmacologic and nonpharmacologic treatments for …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.